Which of the following drugs is an antithyroid medication?

Choice A rationale

Dehydration is not a primary complication directly associated with beta-blocker use. Beta-blockers, such as propranolol or metoprolol, primarily affect the cardiovascular system by blocking beta-adrenergic receptors, which decreases heart rate and blood pressure. Dehydration is typically caused by inadequate fluid intake or excessive fluid loss from conditions like vomiting, diarrhea, or diuresis.

Choice B rationale

Hyperkalemia is an elevated potassium level, which is a rare side effect of non-selective beta-blockers, but not a primary complication to monitor for in a patient taking a beta-blocker for hypertension. Hyperkalemia is more commonly associated with conditions like renal failure or the use of certain medications, such as ACE inhibitors or potassium-sparing diuretics.

Choice C rationale

Beta-blockers can mask the physiological signs of hypoglycemia in patients with diabetes, such as tremors, palpitations, and tachycardia. This occurs because the drugs block the sympathetic nervous system's compensatory response to low blood glucose, which normally involves the release of epinephrine. Consequently, a patient may not recognize a hypoglycemic event until it becomes severe.

Choice D rationale

Angina is a symptom of myocardial ischemia, and beta-blockers are often used to prevent it, not cause it. By reducing the heart rate and contractility, beta-blockers decrease myocardial oxygen demand. This effect helps to prevent chest pain associated with angina, making it a therapeutic benefit rather than a potential complication.

Choice A rationale

The HbA1c test measures the average blood glucose concentration over the past two to three months by assessing the amount of glycated hemoglobin in red blood cells. It does not differentiate between type 1 or type 2 diabetes mellitus, as both conditions can result in elevated blood glucose levels and thus an elevated HbA1c reading. A diagnosis of type 1 versus type 2 diabetes requires a different diagnostic approach.

Choice B rationale

The HbA1c test measures the percentage of hemoglobin with glucose molecules attached. This is an indicator of long-term average blood glucose control and is not a marker for infection. Infections can cause an acute increase in blood glucose levels but do not directly or immediately affect the HbA1c, which reflects a longer-term trend. The normal HbA1c is below 5.7%.

Choice C rationale

Glycated hemoglobin forms when hemoglobin in red blood cells binds to glucose in the bloodstream. Since red blood cells have a lifespan of approximately 120 days, the HbA1c level reflects the average blood glucose concentration over the preceding two to three months. This provides a valuable metric for assessing patient adherence to diet, exercise, and medication regimens over an extended period.

Choice D rationale

The HbA1c value represents the average blood glucose level over a two to three month period, not the patient’s current or fasting blood glucose level. A fasting blood glucose test measures the glucose concentration in the blood at a single point in time, specifically after at least eight hours of not eating. These two tests provide different snapshots of glycemic control.